• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Provention bio....really?

anonymous

Guest
Sanofi has been trying to end the diabetes line for years.

Sure, this is type 1, and just like usual, way overpaid.

What a waste. There are so many other small biotechs with better oncology and rare disease companies out there.
 






















Sanofi overpaid for Provention Bio. There are not enough Tzield prescriptions. Sanofi will have to pay massive amount of money to prepare the market for the competition.
 
















Sanofi couldn't pick a winner in a one horse race. Everything they touch turns to shit. The only success they've had is with co-promotes. They can't do anything on their own. What a complete shitshow. The Frogs can't do anything right.
 












PVB OG’s are leaving every week. I’d be surprised if 1/2 are still here a year from now. We made our money and finding other rare jobs out there. Suck it Sanofi. Toxic shit hole.